GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hill-Rom Holdings Inc (NYSE:HRC) » Definitions » Debt-to-Equity

Hill-Rom Holdings (Hill-Rom Holdings) Debt-to-Equity : 1.10 (As of Sep. 2021)


View and export this data going back to 1989. Start your Free Trial

What is Hill-Rom Holdings Debt-to-Equity?

Hill-Rom Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $236 Mil. Hill-Rom Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2021 was $1,825 Mil. Hill-Rom Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $1,880 Mil. Hill-Rom Holdings's debt to equity for the quarter that ended in Sep. 2021 was 1.10.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hill-Rom Holdings's Debt-to-Equity or its related term are showing as below:

HRC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14   Med: 0.35   Max: 1.95
Current: 1.1

During the past 13 years, the highest Debt-to-Equity Ratio of Hill-Rom Holdings was 1.95. The lowest was 0.14. And the median was 0.35.

HRC's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs HRC: 1.10

Hill-Rom Holdings Debt-to-Equity Historical Data

The historical data trend for Hill-Rom Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hill-Rom Holdings Debt-to-Equity Chart

Hill-Rom Holdings Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 1.22 1.55 1.09 1.10

Hill-Rom Holdings Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.06 0.94 0.95 1.10

Competitive Comparison of Hill-Rom Holdings's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Hill-Rom Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hill-Rom Holdings's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hill-Rom Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hill-Rom Holdings's Debt-to-Equity falls into.



Hill-Rom Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hill-Rom Holdings's Debt to Equity Ratio for the fiscal year that ended in Sep. 2021 is calculated as

Hill-Rom Holdings's Debt to Equity Ratio for the quarter that ended in Sep. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hill-Rom Holdings  (NYSE:HRC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Hill-Rom Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hill-Rom Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hill-Rom Holdings (Hill-Rom Holdings) Business Description

Traded in Other Exchanges
N/A
Address
130 East Randolph Street, Suite 1000, Chicago, IL, USA, 60601
Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.
Executives
Mary Kay Ladone officer: SVP, Corp. Dev., Strat. & IR 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Deborah Rasin officer: SVP, Chief Legal Officer TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601
Paul Sherwood Johnson officer: SVP & Pres. - PSS Acute Care TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601
Andreas G Frank officer: SVP, Pres. Front Line Care C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner officer: Corporate Controller 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Amy M. Dodrill officer: President - Surgical Solutions 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Gary Lee Ellis director THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420
Mary Garrett director ETHAN ALLEN DRIVE, DANBURY CT 06811
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
William Kucheman director C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447
James R Giertz director
Ronald A Malone director 3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747
Felicia F Norwood director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
William G Dempsey director C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425
Nancy M Schlichting director 200 WILMOT ROAD, DEERFIELD IL 60015